NL-OMON21194
Completed
Not Applicable
Adherence and patients’ experiences with oral anticancer agents.
VU University Medical Center0 sites200 target enrollmentTBD
Conditionscancer
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- cancer
- Sponsor
- VU University Medical Center
- Enrollment
- 200
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
/A
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with cancer of 18 years and older who have filled at least one prescription for an oral anticancer agent in the past period of three months.
Exclusion Criteria
- •1\. Patients younger than 18 years;
- •2\. Treatment in the (neo)adjuvant setting;
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Adherence and patients’ experiences with capecitabine.Colorectal cancer, gastric cancer and breast cancer.NL-OMON21382VU University Medical Center66
Completed
Not Applicable
Adherence and patients’ experiences with erlotinib.CancerOral chemotherapyErlotinibAdherencePlasma concentrationLongkankerOrale chemotherapieErlotinibTherapietrouwPlasmaconcentratieNL-OMON26332VU medical centre, Amsterdam50
Completed
Not Applicable
Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?SchizophreniaSchizoaffectiveNCT00223522The University of Texas Health Science Center at San Antonio50
Completed
Not Applicable
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrYAtrial FibrillationNCT03790917National Research Center for Preventive Medicine201
Completed
Not Applicable
Survey on Medication Adherence to Direct Oral Anticoagulants in Patients with Non-Valvular Atrial Fibrillation (NVAF)on-Valvular Atrial FibrillationJPRN-UMIN000034176Rakuwakai Otowa Hospital1,000